Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EOG Resources
EOG
|
+$727M |
| 2 |
Home Depot
HD
|
+$472M |
| 3 |
Pfizer
PFE
|
+$362M |
| 4 |
Texas Instruments
TXN
|
+$314M |
| 5 |
LyondellBasell Industries
LYB
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$567M |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$245M |
| 3 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$242M |
| 4 |
AT&T
T
|
+$170M |
| 5 |
Accenture
ACN
|
+$167M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.07% |
| 2 | Financials | 12.97% |
| 3 | Healthcare | 12.01% |
| 4 | Consumer Discretionary | 10.22% |
| 5 | Industrials | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Janux Therapeutics
JANX
$934M
| $637K | ﹤0.01% |
44,400
+10,454
| +31% | +$171K |
|
3027
Kura Sushi USA
KRUS
$580M
| $637K | ﹤0.01% |
11,537
+1,162
| +11% | +$60K |
|
3028
Rimini Street
RMNI
$447M
| $637K | ﹤0.01% |
109,683
+3,307
| +3% | +$17.4K |
|
3029
SoundThinking
SSTI
$102M
| $636K | ﹤0.01% |
22,938
| – | – |
|
3030
Valhi
VHI
$380M
| $636K | ﹤0.01% |
21,686
+7,274
| +50% | +$198K |
|
3031
Altimmune
ALT
$583M
| $635K | ﹤0.01% |
104,222
+3,402
| +3% | +$25.1K |
|
3032
Citius Pharmaceuticals
CTXR
$16.4M
| $632K | ﹤0.01% |
14,114
+2,763
| +24% | +$109K |
|
|
MCBC
3033
DELISTED
Macatawa Bank Corp
MCBC
| $630K | ﹤0.01% |
69,819
-1,895
| -3% | -$17.4K |
|
|
TCRR
3034
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $628K | ﹤0.01% |
227,529
-7,724
| -3% | -$24.3K |
|
3035
Red River Bancshares
RRBI
$670M
| $626K | ﹤0.01% |
11,813
+210
| +2% | +$10.9K |
|
|
LUNA
3036
DELISTED
Luna Innovations Incorporated
LUNA
| $625K | ﹤0.01% |
81,051
+3,841
| +5% | +$27.6K |
|
3037
Lennar Class B
LEN.B
$20.1B
| $623K | ﹤0.01% |
9,584
+319
| +3% | +$23.6K |
|
|
DZSI
3038
DELISTED
DZS Inc. Common Stock
DZSI
| $622K | ﹤0.01% |
44,800
| – | – |
|
|
NUVL
3039
DELISTED
Nuvalent
NUVL
| $618K | ﹤0.01% |
44,429
+17,257
| +64% | +$251K |
|
3040
Limoneira
LMNR
$239M
| $616K | ﹤0.01% |
41,924
+601
| +1% | +$8.74K |
|
|
FRBK
3041
DELISTED
Republic First Bancorp Inc
FRBK
| $615K | ﹤0.01% |
119,056
+4,824
| +4% | +$23.2K |
|
3042
Riley Exploration Permian
REPX
$740M
| $610K | ﹤0.01% |
+24,298
| New | +$652K |
|
3043
Pure Cycle
PCYO
$258M
| $605K | ﹤0.01% |
50,284
-4
| -0% | -$50 |
|
|
JBIO
3044
Jade Biosciences
JBIO
$1.17B
| $603K | ﹤0.01% |
939
+232
| +33% | +$90K |
|
3045
FS Bancorp
FSBW
$314M
| $601K | ﹤0.01% |
19,387
+563
| +3% | +$18.3K |
|
3046
Acacia Research
ACTG
$447M
| $597K | ﹤0.01% |
132,184
| – | – |
|
3047
Blend Labs
BLND
$467M
| $596K | ﹤0.01% |
104,457
+2,252
| +2% | +$17.4K |
|
3048
First Bank
FRBA
$471M
| $594K | ﹤0.01% |
41,739
+2,159
| +5% | +$31K |
|
3049
ACV Auctions
ACVA
$1.36B
| $593K | ﹤0.01% |
40,014
+4,107
| +11% | +$57.1K |
|
3050
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
| $593K | ﹤0.01% |
7,214
-35
| -0.5% | -$2.93K |
|
Similar funds
Charles Schwab's Q1 2022 Portfolio in Review
As of Q1 2022, Charles Schwab held 3,695 positions worth $333B, down 1.7% from $339B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Charles Schwab deployed $10.7B of net new capital in Q1 2022, opening 106 new positions and adding to 2,783 existing holdings. Its largest new stake was Constellation Energy: 1,449,939 shares worth $81.6M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Emerson Electric, an estimated $567M trimmed.
- Charles Schwab's largest Q1 2022 buy was Constellation Energy: 1,449,939 shares worth $81.6M.
- Charles Schwab added most to EOG Resources in Q1 2022, an estimated $727M increase.
- Charles Schwab's biggest Q1 2022 reduction was Emerson Electric, cutting an estimated $567M.
- Charles Schwab fully exited Xilinx Inc in Q1 2022, selling an estimated $245M.
- Charles Schwab's ten largest holdings make up 18% of its $333B portfolio in Q1 2022.
- Charles Schwab opened 106 new positions and closed 115 in Q1 2022.
- Charles Schwab's portfolio value fell 1.7% quarter-over-quarter to $333B.
Based on Charles Schwab's 13F filing for Q1 2022, filed 13 May 2022.